Wei Ren

5.0k total citations
164 papers, 3.5k citations indexed

About

Wei Ren is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wei Ren has authored 164 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 31 papers in Pulmonary and Respiratory Medicine and 24 papers in Oncology. Recurrent topics in Wei Ren's work include Nanoparticle-Based Drug Delivery (10 papers), Aortic Disease and Treatment Approaches (9 papers) and interferon and immune responses (8 papers). Wei Ren is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Aortic Disease and Treatment Approaches (9 papers) and interferon and immune responses (8 papers). Wei Ren collaborates with scholars based in China, United States and Macao. Wei Ren's co-authors include Ye Liu, Sijin Yang, Ting Zhong, Xuan Zhang, Dan Huang, Liuqun Gu, Xin Yao, Seeram Ramakrishna, Lingling Tian and Dan Kai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Wei Ren

156 papers receiving 3.4k citations

Peers

Countries citing papers authored by Wei Ren

Since Specialization

Citations

This map shows the geographic impact of Wei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ren more than expected).

Fields of papers citing papers by Wei Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ren. The network helps show where Wei Ren may publish in the future.

Co-authorship network of co-authors of Wei Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ren. A scholar is included among the top collaborators of Wei Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ren. Wei Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Research progress on nanoplatforms based delivery of traditional Chinese medicine against multi-drug resistance in breast cancer 2025 ·Phytomedicine ·(unknown), (unknown), Yanan Zhou, Yuesheng Wang, (unknown), Qin Sun, (unknown), (unknown), Wenjun Miao, Wei Ren	0
2	Biomarcadores Potenciais na Fibrose Miocárdica: Uma Análise Bioinformática 2024 ·Arquivos Brasileiros de Cardiologia ·(unknown), Gang Luo, Ping Liu, Wei Ren, Sijin Yang	1
3	Prediction of lymphovascular invasion in esophageal squamous cell carcinoma by computed tomography-based radiomics analysis: 2D or 3D ? 2024 ·Cancer Imaging ·Yang Li, (unknown), (unknown), Qi Wang, (unknown), (unknown), Yue Meng, Ming‐Bo Wang, (unknown), Jialiang Ren, Wei Ren, Gaofeng Shi	1
4	Exploring the Mechanism of Asiatic Acid against Atherosclerosis Based on Molecular Docking, Molecular Dynamics, and Experimental Verification 2024 ·Pharmaceuticals ·Zhihao Wu, (unknown), (unknown), Jie Yang, Pan Liang, Wei Ren, Hong Yu	1
5	Zhilong Huoxue Tongyu capsule protects against atherosclerosis by suppressing EndMT via modulating Hippo/YAP signaling pathway 2024 ·Journal of Traditional and Complementary Medicine ·Yanan Zhou, Hong Wang, (unknown), Pan Liang, Xinyue Liu, Hongping Shen, Qin Sun, Gang Luo, (unknown), Sijin Yang, Wei Ren	0
6	The correlation between serum uric acid and diabetic kidney disease in type 1 diabetes patients in Anhui, China 2023 ·BMC Nephrology ·Jun Jiang, (unknown), Lei Lan, Wei Ren	3
7	Carbonized Platycladus orientalis Derived Carbon Dots Accelerate Hemostasis through Activation of Platelets and Coagulation Pathways 2023 ·Small ·Pan Liang, (unknown), Yanan Zhou, (unknown), Yining Ma, Houping Xu, Hongping Shen, Wei Ren, Sijin Yang	24
8	Zhilong Huoxue Tongyu capsule alleviates myocardial fibrosis by improving endothelial cell dysfunction 2023 ·Journal of Traditional and Complementary Medicine ·(unknown), Yanan Zhou, (unknown), Pan Liang, Jiali Liu, (unknown), Guilin Ren, Maryam Mazhar, Hongping Shen, (unknown), (unknown), (unknown), Gang Luo, Sijin Yang, Wei Ren	2
9	The therapeutic value of bifidobacteria in cardiovascular disease 2023 ·npj Biofilms and Microbiomes ·Jia Tang, Yumeng Wei, Chao Pi, (unknown), (unknown), Peng Shi, Jinglin Chen, (unknown), Tao Chen, Huiyang Liu, (unknown), (unknown), Wei Ren, Peng Cao, Nan Zeng, Ling Zhao	26
10	Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), Pei Li, (unknown), Qian Wang, Chenglong Wang, Yan Liu, Yiping Deng, Zongquan Zhang, (unknown), (unknown), Wei Ren, Chunhong Li	15
11	DUX: One Transcription Factor Controls 2-Cell-like Fate 2022 ·International Journal of Molecular Sciences ·Wei Ren, (unknown), (unknown), Wen Deng, Jinlian Hua, Fan Yang	8
12	Exploring the Ferroptosis Mechanism of Zhilong Huoxue Tongyu Capsule for the Treatment of Intracerebral Hemorrhage Based on Network Pharmacology and In Vivo Validation 2022 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Wei Ren, Li Wang, (unknown), Maryam Mazhar, (unknown), Houping Xu, Sijin Yang	6
13	Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p/NLRP3 2022 ·Evidence-based Complementary and Alternative Medicine ·Mengnan Liu, Gang Luo, (unknown), (unknown), (unknown), Wei Ren, (unknown), (unknown), Hua Zhou, Sijin Yang	10
14	Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics 2022 ·Molecules ·Pan Liang, Yining Ma, (unknown), (unknown), Qin Sun, Changzhen Sun, Zengjin Liu, Maryam Mazhar, Sijin Yang, Wei Ren	7
15	Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy 2021 ·Pharmaceutics ·Pan Liang, (unknown), Yanli Dong, Zhenwen Zhao, Qin Sun, Maryam Mazhar, Yining Ma, Sijin Yang, Wei Ren	36
16	Developing IR-780 as a Novel Matrix for Enhanced MALDI MS Imaging of Endogenous High-Molecular-Weight Lipids in Brain Tissues 2019 ·Analytical Chemistry ·Na Li, Peng Wang, Xiaolong Liu, Chao Han, Wei Ren, Tuo Li, Xing Li, (unknown), Zhenwen Zhao	17
17	Comparative Study of the Chemical Constituents and Bioactivities of the Extracts from Fruits, Leaves and Root Barks of Lycium barbarum 2019 ·Molecules ·Xiao Xiao, Wei Ren, Nan Zhang, Tao Bing, Xiangjun Liu, Zhenwen Zhao, Dihua Shangguan	45
18	Photoluminescence Enhancement of Carbon Dots by Surfactants at Room Temperature 2018 ·Chemistry - A European Journal ·Wei Ren, Shiqing Chen, Shumu Li, Yangyang Zhang, Jianan Liu, Ming Guan, Hui Yang, Na Li, Chao Han, Tuo Li, Zhenwen Zhao, Jiechao Ge	22
19	Near-infrared fluorescent carbon dots encapsulated liposomes as multifunctional nano-carrier and tracer of the anticancer agent cinobufagin in vivo and in vitro 2018 ·Colloids and Surfaces B Biointerfaces ·Wei Ren, Shiqing Chen, (unknown), Shumu Li, Jiechao Ge, (unknown), Qing Huo, Yangyang Zhang, Zhenwen Zhao	47
20	Application of KDQOL-SFTM 1.3 version in evaluating quality of life of maintenance hemodialysis patients in multiple centers 2016 ·Liya Wang, Deguang Wang, Xiujun Zhang, Lei Chen, (unknown), (unknown), Jianjun Zhu, Bei Xiao, Li Liu, Wei Ren	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact